Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25

Nature Immunology

Volumn 13, Issue 11, 2012, Pages 1110-1117

  Zhong, Bo ^a   Liu, Xikui ^a   Wang, Xiaohu ^a   Chang, Seon Hee ^a   Liu, Xindong ^a   Wang, Aibo ^a   Reynolds, Joseph M ^a   Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACT1 PROTEIN; ADAPTOR PROTEIN; CXCL1 CHEMOKINE; I KAPPA B ALPHA; INTERLEUKIN 17; JANUS KINASE; MESSENGER RNA; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE 25; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; GENE OVEREXPRESSION; HALF LIFE TIME; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CHEMOKINE CXCL1; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-17; MAP KINASE KINASE 4; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 5; TNF RECEPTOR-ASSOCIATED FACTOR 6; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84867729539     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2427     Document Type: Article

References (50)

1. Iwakura, Y., Ishigame, H., Saijo, S. & Nakae, S. Functional specialization of interleukin-17 family members. Immunity 34, 149-162 (2011).
2. Yang, X.O. et al. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (2008).
3. Kagami, S., Rizzo, H.L., Kurtz, S.E., Miller, L.S. & Blauvelt, A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185, 5453-5462 (2010).
4. Gaffen, S.L. Recent advances in the IL-17 cytokine family. Curr. Opin. Immunol. 23, 613-619 (2011).
5. Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133-1141 (2005).
6. Dong, C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat. Rev. Immunol. 6, 329-333 (2006).
7. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
8. Cua, D.J. & Tato, C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10, 479-489 (2010).
9. Chang, S.H. & Dong, C. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell. Signal. 23, 1069-1075 (2011).
10. Hartupee, J., Liu, C., Novotny, M., Li, X. & Hamilton, T. IL-17 enhances chemokine gene expression through mRNA stabilization. J. Immunol. 179, 4135-4141 (2007).
11. Wright, J.F. et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol. 181, 2799-2805 (2008).
12. Hu, Y. et al. IL-17RC is required for IL-17A-and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis. J. Immunol. 184, 4307-4316 (2010).
13. Chang, S.H., Park, H. & Dong, C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281, 35603-35607 (2006).
14. Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247-256 (2007).
15. Liu, C. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci. Signal. 2, ra63 (2009).
16. Bulek, K. et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat. Immunol. 12, 844-852 (2011).
17. Reyes-Turcu, F.E., Ventii, K.H. & Wilkinson, K.D. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397 (2009).
18. Lin, S.C. et al. Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20. J. Mol. Biol. 376, 526-540 (2008).
19. Li, S. et al. Regulation of virus-triggered signaling by OTUB1-and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 285, 4291-4297 (2010).
20. Valero, R. et al. USP25, a novel gene encoding a deubiquitinating enzyme, is located in the gene-poor region 21q11.2. Genomics 62, 395-405 (1999).
21. Chang, S.H. & Dong, C. IL-17F: regulation, signaling and function in inflammation. Cytokine 46, 7-11 (2009).
22. Wang, X. et al. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity 36, 23-31 (2012).
23. Chang, S.H. et al. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity 35, 611-621 (2011).
24. Denuc, A., Bosch-Comas, A., Gonzalez-Duarte, R. & Marfany, G. The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS ONE 4, e5571 (2009).
25. Sun, D. et al. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat. Immunol. 12, 853-860 (2011).
26. May, M.J. IL-17R signaling: new players get in on the Act1. Nat. Immunol. 12, 813-815 (2011).
27. Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102-4112 (2007).
28. Shi, P. et al. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1. Sci. Signal. 4, ra73 (2011).
29. Skaug, B., Jiang, X. & Chen, Z.J. The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769-796 (2009).
30. Boone, D.L. et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060 (2004).
31. Ea, C.K., Sun, L., Inoue, J. & Chen, Z.J. TIFA activates IκB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6. Proc. Natl. Acad. Sci. USA 101, 15318-15323 (2004).
32. Mao, A.P. et al. Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J. Biol. Chem. 285, 9470-9476 (2010).
33. Deng, L. et al. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361 (2000).
34. Wang, C. et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351 (2001).
35. Kanayama, A. et al. TAB2 and TAB3 activate the NF-κB pathway through binding to polyubiquitin chains. Mol. Cell 15, 535-548 (2004).
36. Xia, Z.P. et al. Direct activation of protein kinases by unanchored polyubiquitin chains. Nature 461, 114-119 (2009).
37. Fan, Y. et al. Lysine 63-linked polyubiquitination of TAK1 at lysine 158 is required for tumor necrosis factor α-and interleukin-1β-induced IKK/NF-κB and JNK/AP-1 activation. J. Biol. Chem. 285, 5347-5360 (2010).
38. Xu, M., Skaug, B., Zeng, W. & Chen, Z.J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFα and IL-1β. Mol. Cell 36, 302-314 (2009).
39. Zeng, W. et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330 (2010).
40. Gack, M.U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
41. Zhu, S. et al. Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling. J. Exp. Med. 207, 2647-2662 (2010).
42. He, J.Q., Oganesyan, G., Saha, S.K., Zarnegar, B. & Cheng, G. TRAF3 and its biological function. Adv. Exp. Med. Biol. 597, 48-59 (2007).
43. Maezawa, Y. et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J. Immunol. 176, 1013-1018 (2006).
44. Angkasekwinai, P. et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517 (2007).
45. Bot, J. et al. Culturing mouse peritoneal mesothelial cells. Pathol. Res. Pract. 199, 341-344 (2003).
46. Wang, J. et al. Pneumocystis carinii activates the NF-κB signaling pathway in alveolar epithelial cells. Infect. Immun. 73, 2766-2777 (2005).
47. Bosch-Comas, A., Lindsten, K., Gonzalez-Duarte, R., Masucci, M.G. & Marfany, G. The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins. Cell. Mol. Life Sci. 63, 723-734 (2006).
48. Zhong, B. et al. The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397-407 (2009).
49. Zhong, B. et al. The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation. J. Immunol. 184, 6249-6255 (2010).
50. Li, Q. et al. Tripartite motif 8 (TRIM8) modulates TNFα-and IL-1β-triggered NF-κB activation by targeting TAK1 for K63-linked polyubiquitination. Proc. Natl. Acad. Sci. USA 108, 19341-19346 (2011).